Search

Author/Creator Morris, Joan D.

1. Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL. Issue 9 (29th July 2022)

Authors:
Katz, Deborah A.; Morris, Joan D.; Chu, Michael P.; David, Kevin A.; Thieblemont, Catherine; Morley, Nicholas J.; Khan, Sharif S.; Viardot, Andreas; Martín García-Sancho, Alejandro; Rodríguez-García, Guillermo; Bastos-Oreiro, Mariana; Lee, Seung Tae; Kormany, William; Chen, Yuqi; Wong, Hansen L.;...
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 9(2022)
Page Start:
2063
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia. Issue 4 (11th February 2020)

Authors:
Kiyoi, Hitoshi; Morris, Joan D.; Oh, Iekuni; Maeda, Yoshinobu; Minami, Hironobu; Miyamoto, Toshihiro; Sakura, Toru; Iida, Hiroatsu; Tuglus, Catherine A.; Chen, Yuqi; Dos Santos, Cedric; Kalabus, James; Anderson, Abraham; Hata, Tomoko; Nakashima, Yasuhiro; Kobayashi, Yukio
Journal:
Cancer science
Issue:
Volume 111:Issue 4(2020)
Page Start:
1314
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search